Breast Cancer Clinical Trial
— COG-SPORTIFOfficial title:
Study of Impact of Adapted Physical Activity on Cognitive Functions and Quality of Life in Patients Treated for Locally Advanced Breast Cancer
| NCT number | NCT02934880 |
| Other study ID # | CHB16.01 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 2016 |
| Est. completion date | April 2019 |
Breast cancer is the most frequent cancer in women in western countries. The improvement of
therapeutic management associated to the developement of supportive care allows patient to
live longer in better conditions. But several studies have showed the deleterious impact of
treatment such as chemotherapy on cognition. To limit these damages, non therapeutic
approaches such as Adapted Physical Activity (APA) have been developped.
The goal of this study is to evaluate the benefit of APA program on cognitive functions in
patients with locally advanced breast cancer.
| Status | Recruiting |
| Enrollment | 152 |
| Est. completion date | April 2019 |
| Est. primary completion date | January 2019 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Women - More than 18 years old - Locally advanced breast cancer - Patient who undergone surgery - Cognitive complaint (FACT-COG inferior or equal to 8/16) - No metastasis at the inclusion - Patient who received adjuvant therapy by chemotherapy - Patient with a social protection - Barbizet scale Superior or equal to 3 - No neurological history - No medical contraindication to APA - Inform consent signed Exclusion Criteria: - Metastatic breast cancer - History of other cancer (in 5 years before inclusion) - Current chemotherapy or radiotherapy - Chemotherapy or radiotherapy ended for more than 6 months - Current APA program - Blood transfusion for less than 6 mois - Minimal mental score inferior to normal - Patient no able to respond to the cognitive test - Patient no able to realize APA program - Drug use - Alcohol abuse - Patient Under guardianship or curatorship or deprived of liberty |
| Country | Name | City | State |
|---|---|---|---|
| France | Centre François Baclesse | Caen | |
| France | Centre Oscar Lambret | Lille | |
| France | Centre Henri Becquerel | Rouen |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Henri Becquerel |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | proportion of patient with an increase of Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG) result | Proportion of patient with an increase superior or equal to seven points between FACT-COG at the inclusion and FACT-COG after APA program | After APA program | |
| Secondary | Improval of quality of life | Impact of APA on quality of life (FACT-B result) | After APA program | |
| Secondary | Comparison of immediate APA and delayed APA on quality of life | Comparison between FACT-B, FACT-COG and FACIT-F results in the two groups | 30 months | |
| Secondary | Study of relations between cognitive functions and quality pf life | Correlation between patient questionnaire and data of psychological tests done by neuropsychologist | After APA program |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |